Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Inv. presentation
Director departure
|
|
NovaBay Pharmaceuticals, Inc. (NBY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 5% stake in Novabay Pharmaceuticals, Inc. |
| 01/23/2020 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in NovaBay Pharmaceuticals, Inc. |
| 02/11/2015 |
SC 13G/A
| Najafi Ramin reports a 8% stake in NOVABAY PHARMACEUTICALS, INC. |
| 02/14/2014 |
SC 13G/A
| Najafi Ramin reports a 8.6% stake in NOVABAY PHARMACEUTICALS, INC. |
| 02/12/2014 |
SC 13G/A
| Iroquois Capital Management, LLC reports a 2.9% stake in NOVABAY PHARMACEUTICALS, INC. |
| 12/04/2013 |
SC 13G/A
| Pioneer Pharma Pte. Ltd. reports a 15.7% stake in NovaBay Pharmaceuticals, Inc. |
| 12/03/2013 |
SC 13G/A
| Pioneer Pharma Pte. Ltd. reports a 9.7% stake in NovaBay Pharmaceuticals, Inc. |
| 02/19/2013 |
SC 13G/A
| Pioneer Pharma Pte. Ltd. reports a 10.6% stake in NOVABAY PHARMACEUTICALS, INC. |
| 02/14/2013 |
SC 13G/A
| KINGSBROOK PARTNERS LP reports a 2.9% stake in NovaBay Pharmaceuticals, Inc. |
| 02/11/2013 |
SC 13G/A
| Najafi Ramin reports a 10.3% stake in NOVABAY PHARMACEUTICALS, INC. |
| 02/13/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2012 |
SC 13G/A
| NovaBay Pharmaceuticals, Inc. reports a 12.4% stake in NOVABAY PHARMACEUTICALS, INC. |
| 02/04/2011 |
SC 13G/A
| NovaBay Pharmaceuticals, Inc. reports a 14.2% stake in NOVABAY PHARMACEUTICALS, INC. |
| 02/13/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
|
|